Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.91204 | 82 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.15157 | 83 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.22137 | 77 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.24322 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.28403 | 84 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.66916 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.21115 | 78 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.64217 | 80 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.3296 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.88885 | 81 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.32775 | 78 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.84026 | 81 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.71587 | 81 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.89346 | 82 |